2017
High-Dose-Rate Brachytherapy As Monotherapy for Prostate Cancer: A Meta-analysis of Biochemical Control Rates and Dose Fractionation
Tien C, Chen Z, Carlson D. High-Dose-Rate Brachytherapy As Monotherapy for Prostate Cancer: A Meta-analysis of Biochemical Control Rates and Dose Fractionation. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e621. DOI: 10.1016/j.ijrobp.2017.06.2099.Peer-Reviewed Original Research
1998
Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine‐125 interstitial implants
Nath R, Roberts K, Ng M, Peschel R, Chen Z. Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine‐125 interstitial implants. Medical Physics 1998, 25: 2293-2307. PMID: 9874821, DOI: 10.1118/1.598440.Peer-Reviewed Original ResearchConceptsSurvival rateProstate cancerInterstitial implantsLocal recurrence-free survival rateRecurrence-free survival ratesLocal control rateLocal tumor controlExcellent clinical resultsProstate cancer patientsUnfavorable groupClinical efficacyCancer patientsControl rateTumor controlClinical resultsFavorable groupDose coveragePatientsDosimetric parametersDosimetry parametersIsodose surfaceSignificant differencesVirginia studyUnfavorable parametersCancer